136 related articles for article (PubMed ID: 1710844)
1. Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A.
Metcalfe S; Milner J
Transplantation; 1991 Jun; 51(6):1318-20. PubMed ID: 1710844
[No Abstract] [Full Text] [Related]
2. Phosphatases PP1 and PP2A act after the G0/G1 interface in lymphocyte activation.
Metcalfe S; Milner J
Immunol Lett; 1990 Nov; 26(2):177-82. PubMed ID: 1702753
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Takase K; Gelfand EW
Biochem Biophys Res Commun; 1992 Aug; 186(3):1315-21. PubMed ID: 1380801
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
Zheng B; Shorthouse R; Masek MA; Berry G; Billingham ME; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):851-5. PubMed ID: 1703717
[No Abstract] [Full Text] [Related]
5. Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin.
Siekierka JJ
Immunol Res; 1994; 13(2-3):110-6. PubMed ID: 7539823
[TBL] [Abstract][Full Text] [Related]
6. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
7. Mechanism of action of rapamycin (Sirolimus, Rapamune).
Molnar-Kimber KL
Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
[No Abstract] [Full Text] [Related]
8. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of T and B lymphocyte proliferation by rapamycin.
Kay JE; Kromwel L; Doe SE; Denyer M
Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
[TBL] [Abstract][Full Text] [Related]
10. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
[No Abstract] [Full Text] [Related]
11. Regulation of the nuclear factor of activated T cells in stably transfected Jurkat cell clones.
Li W; Handschumacher RE
Biochem Biophys Res Commun; 1996 Feb; 219(1):96-9. PubMed ID: 8619834
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
13. A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge.
Lorber MI; Wilson JH; Harding MW; Gromkowski S; Marks WH
Transplantation; 1991 Jul; 52(1):167-70. PubMed ID: 1713364
[No Abstract] [Full Text] [Related]
14. Activation of peripheral large granular lymphocytes with the serine/threonine phosphatase inhibitor, okadaic acid.
McVicar DW; Mason AT; Bere EW; Ortaldo JR
Eur J Immunol; 1994 Jan; 24(1):165-70. PubMed ID: 8020552
[TBL] [Abstract][Full Text] [Related]
15. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
Mattila PS
Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
[No Abstract] [Full Text] [Related]
16. Rapamycin.
Carlson RP; Sehgal SN; Lewis AJ
Clin Exp Rheumatol; 1993; 11 Suppl 8():S129. PubMed ID: 8324938
[No Abstract] [Full Text] [Related]
17. Okadaic acid enhances human T cell activation and phosphorylation of an internal substrate induced by phorbol myristate acetate.
Tada Y; Yoshizawa S; Nagasawa K; Furugo I; Tsuru T; Mayumi T; Tsukamoto H; Niho Y
Immunopharmacology; 1992; 24(1):17-24. PubMed ID: 1333455
[TBL] [Abstract][Full Text] [Related]
18. Alterations in activities of protein phosphatases PP1 and PP2A in T and B lymphocytes of autoimmune MRL/MpJ-lpr/lpr mice.
Zhu T; Matsuzawa S; Mizuno Y; Kikuchi K
J Biochem; 1993 Jul; 114(1):50-4. PubMed ID: 8407876
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells.
Metcalfe SM; Richards FM
Transplantation; 1990 Apr; 49(4):798-802. PubMed ID: 1691537
[TBL] [Abstract][Full Text] [Related]
20. Factors responsible for the Ca(2+)-dependent inactivation of calcineurin in brain.
Stemmer PM; Wang X; Krinks MH; Klee CB
FEBS Lett; 1995 Oct; 374(2):237-40. PubMed ID: 7589543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
